RSS

Gene therapies

The Centre for Process Innovation (CPI) has announced it has overcome a significant bottleneck in the development of gene therapies. Read more

News

Clive Glover, strategy director and cell and gene therapy lead at Pall Corporation, explains why we need to take a more holistic approach to gene therapy manufacturing processes. Read more

Opinion

Contract drug manufacturer Catalent has completed its $1.2 billion acquisition of gene therapy manufacturer Paragon Bioservices, the company has announced. Read more

News